PYC Therapeutics Limited
PYC
Rank in Stocks
#9736
PYC Therapeutics Limited, a drug-development company, engages in the discovery... PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia. The company offers VP-001, a drug program, which is in Phase 1 clinical trial for the treatment of retinitis pigmentosa type 11; PYC-001, a drug candidate for treating blinding eye disease named Autosomal Dominant Optic Atrophy, which is in clinical studies; PYC-002, a drug program for the treatment of severe neurodevelopmental disorder named Phelan-McDermid Syndrome, which is in pre-clinical studies; and PYC-003 to treat autosomal dominant polycystic kidney disease, which is in early-stage clinical trials. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to support drug discovery and development efforts in the field of neurodegenerative disorders. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.
Share Price
$1.37
Last synced: 2026-11-10
Market Cap
$799.09M
Change (1 day)
0.38%
Change (1 year)
76.49%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade PYC Therapeutics Limited (PYC)
Category
Healthcare
Operating Margin for PYC Therapeutics Limited (PYC)
Operating Margin as of November 2026 TTM: 0.00%
According to PYC Therapeutics Limited's latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of -228.26%.
Operating Margin history for PYC Therapeutics Limited from 2005 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | -100.00% |
| 2025 | -228.26% | 29.58% |
| 2024 | -176.15% | -28.91% |
| 2023 | -247.77% | 31.59% |
| 2022 | -188.29% | -73.49% |
| 2021 | -710.16% | 75.36% |
| 2020 | -404.97% | 0.00% |
| 2019 | 0.00% | -100.00% |
| 2018 | -20,157.14% | 12,998.41% |
| 2017 | -153.89% | -99.97% |
| 2016 | -553,065.06% | 91,005.50% |
| 2015 | -607.06% | -12.61% |
| 2014 | -694.64% | -18.99% |
| 2013 | -857.51% | 304.58% |
| 2012 | -211.95% | 34.46% |
| 2011 | -157.63% | -79.85% |
| 2010 | -782.30% | 169.38% |
| 2009 | -290.41% | -95.27% |
| 2008 | -6,141.81% | 260.19% |
| 2007 | -1,705.17% | 0.00% |
| 2006 | 0.00% | -100.00% |
| 2005 | -3,312.50% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about PYC Therapeutics Limited's operating margin
What was PYC Therapeutics Limited's operating margin in 2025?
In 2025, PYC Therapeutics Limited's operating margin was -228.26%, compared with -176.15% in 2024.
How has PYC Therapeutics Limited's operating margin changed since 2020?
From 2020 to 2025, PYC Therapeutics Limited's operating margin was highest in 2024 (-176.15%) and lowest in 2021 (-710.16%).
How does PYC Therapeutics Limited's operating margin compare with similar companies?
PYC Therapeutics Limited's operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.